6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮

3(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one

产品编号.: A725287 CAS号: 36725-28-7
分子式: C11H13N3O 分子量: 203.2404
纯度: 98% MDL NO.:

中文名称:6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮
CAS号:36725-28-7
中文别名:6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮;6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone 6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮;6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-吡唑酮;6-(4-氨基苯基)-5-甲基-3(2H)哒嗪酮;6-(4-氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2H)-酮;已拆分的消旋哒嗪酮
英文名称:3(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
英文别名:6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone;3(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;6-(4-amino-phenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one;6-(4-Aminophenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one;6-(p-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;SKF 93505;Levosimendan dazinones intermediates;6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)pyridazinone;3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-5-methyl-;6-(4'-Aminophenyl)-4,5-dihydro-5-methylpyridazin-3-one;3(2H)-Pyridazin;6-(p-aminophenyl)-5-methyl-4,5-dihydropyridaz-3-one;CHEMBL301353;J-518018;6-(4-aminophenyl)-5-methyl-4,5-dihydro -3(2H)-pyridazinone;6-(4-aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;FT-0639333;GDMRFHZLKNYRRO-UHFFFAOYSA-N;6-(p-aminophenyl)-4,5-dihydro5-methyl-3(2H)-pyridazinone;107295-33-0;NIOSH/UR6330000;(-)-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3-(2H)-pyridazinone;6-(p-aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;A800375;6-(p-aminophenyl)-5-methyl-4,5-dihydropyridazinone;6-(4-amino-phenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;3-(4-aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;SY023998;6-(4-aminophenyl)-5-methyl-2,3,4,5-tetrahydropyridazin-3-one;AC-069;6-(p-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;4,5-dihydro-6-(4-aminophenyl)-5-methyl-3(2H) pyridazinone;6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;3-(4-aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;MFCD01692712;CS-W022429;SCHEMBL934905;(6-(4-aminophenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinone);6-(4-aminophenyl)-4,5-dihydro-5-methylpyridazin-3(2H)one;ICI-109081;AMY24999;BCP22084;Ici 109,081;FT-0600355;AKOS015855644;36725-28-7;6-(4-aminophenyl)-4,5-dihydro-5-methylpyridazinone;DTXSID10957950;6-(4-Aminophenyl)-5-methyl-4 pound not5-dihydropyridazin-3(2H)-one;3(2H)-Pyridazinone, 4,5-dihydro-6-(p-aminophenyl)-5-methyl-;6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2h)-one;UR63300000;BRD-A21608060-001-01-7;6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3-ol;4,5-dihydro-6-(4-aminophenyl)-5-methyl-3(2H)-pyridazinone;GS-3262;Levosimendan Impurity 5;(-)-6-(4-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone
EINEC:
分子式:C11H13N3O
分子量:203.2404
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮
6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone;3(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;6-(4-amino-phenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one;6-(4-Aminophenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one;6-(p-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;SKF 93505;Levosimendan dazinones intermediates;6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)pyridazinone;3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-5-methyl-;6-(4'-Aminophenyl)-4,5-dihydro-5-methylpyridazin-3-one;3(2H)-Pyridazin;6-(p-aminophenyl)-5-methyl-4,5-dihydropyridaz-3-one;CHEMBL301353;J-518018;6-(4-aminophenyl)-5-methyl-4,5-dihydro -3(2H)-pyridazinone;6-(4-aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;FT-0639333;GDMRFHZLKNYRRO-UHFFFAOYSA-N;6-(p-aminophenyl)-4,5-dihydro5-methyl-3(2H)-pyridazinone;107295-33-0;NIOSH/UR6330000;(-)-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3-(2H)-pyridazinone;6-(p-aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;A800375;6-(p-aminophenyl)-5-methyl-4,5-dihydropyridazinone;6-(4-amino-phenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;3-(4-aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;SY023998;6-(4-aminophenyl)-5-methyl-2,3,4,5-tetrahydropyridazin-3-one;AC-069;6-(p-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;4,5-dihydro-6-(4-aminophenyl)-5-methyl-3(2H) pyridazinone;6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone;3-(4-aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one;(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;MFCD01692712;CS-W022429;SCHEMBL934905;(6-(4-aminophenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinone);6-(4-aminophenyl)-4,5-dihydro-5-methylpyridazin-3(2H)one;ICI-109081;AMY24999;BCP22084;Ici 109,081;FT-0600355;AKOS015855644;36725-28-7;6-(4-aminophenyl)-4,5-dihydro-5-methylpyridazinone;DTXSID10957950;6-(4-Aminophenyl)-5-methyl-4 pound not5-dihydropyridazin-3(2H)-one;3(2H)-Pyridazinone, 4,5-dihydro-6-(p-aminophenyl)-5-methyl-;6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2h)-one;UR63300000;BRD-A21608060-001-01-7;6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3-ol;4,5-dihydro-6-(4-aminophenyl)-5-methyl-3(2H)-pyridazinone;GS-3262;Levosimendan Impurity 5;(-)-6-(4-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone